SomaLogic Stock Price, News & Analysis (NASDAQ:SLGCW) $0.17 0.00 (0.00%) (As of 11/30/2023 ET) Add Compare Share Share Today's Range$0.16▼$0.1750-Day Range$0.13▼$0.2452-Week Range$0.13▼$0.79Volume1,484 shsAverage Volume5,340 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media About SomaLogic Stock (NASDAQ:SLGCW)SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for its cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. The company's SOMAmers/SomaScan technology enables researchers to analyze various biological samples for protein biomarker signatures, which are utilized in drug discovery and development. Its SomaScan's biomarker discoveries use in diagnostic applications for various diseases, including cardiovascular and metabolic disease, nonalcoholic steatohepatitis, wellness, and others. The company also provides SomaSignal, a laboratory-developed test. It serves pharmaceutical and biotechnology companies, and academic and government research institutions. The company has a collaboration agreement with Illumina Cambridge, Ltd for the development of co-branded NGS-based proteomic distributable kits. The company was founded in 1999 and is headquartered in Boulder, Colorado.Read More SLGCW Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SLGCW Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive SLGCW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SomaLogic and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ Industry Health Information Services Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SLGCW CUSIPN/A CIK1837412 Webwww.somalogic.com Phone303 625 9000FaxN/AEmployees451Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$81.72 million Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesDr. Stephen A. Williams BS (Age 63)MB, Ph.D., Chief Medical Officer Comp: $648.03kMr. Adam Taich (Age 48)Interim CEO Mr. Eliot M. Lurier CPA (Age 65)Interim Chief Financial Officer Mr. Pi Zheng (Age 50)Interim Chief Accounting Officer Dr. Jason Cleveland Ph.D.Chief Technology OfficerDr. Nebojsa Janjic Ph.D. (Age 62)Chief Science Officer Mr. Ruben Gutierrez J.D. (Age 48)General Counsel Ms. Alison Marie Roelke (Age 48)Chief People Officer Dr. Shane Bowen Ph.D.Chief Research & Development OfficerMore ExecutivesKey CompetitorsAclarionNASDAQ:ACONWBullfrog AINASDAQ:BFRGWCareCloudNASDAQ:CCLDPCareCloudNASDAQ:CCLDOCareCloudNASDAQ:MTBCOView All Competitors SLGCW Stock Analysis - Frequently Asked Questions How have SLGCW shares performed in 2023? SomaLogic's stock was trading at $0.40 at the beginning of the year. Since then, SLGCW stock has decreased by 57.5% and is now trading at $0.17. View the best growth stocks for 2023 here. Are investors shorting SomaLogic? SomaLogic saw a drop in short interest during the month of November. As of November 15th, there was short interest totaling 1,800 shares, a drop of 21.7% from the October 31st total of 2,300 shares. Based on an average trading volume of 4,100 shares, the days-to-cover ratio is currently 0.4 days. View SomaLogic's Short Interest. Who are SomaLogic's major shareholders? SomaLogic's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Concourse Financial Group Securities Inc. (0.00%). How do I buy shares of SomaLogic? Shares of SLGCW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:SLGCW) was last updated on 12/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SomaLogic, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.